Vivos Therapeutics Downgraded Amidst Business Model Challenges VVOS Stock News
VVOS Stock | USD 4.76 0.42 8.11% |
Slightly above 64% of all Vivos Therapeutics' private investors are looking to take a long position. The analysis of overall sentiment of trading Vivos Therapeutics stock suggests that some investors are interested at this time. Vivos Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Vivos Therapeutics' earnings reports, geopolitical events, and overall market trends.
An analyst at Alliance Global Partners has shifted Vivos Therapeutics from a Buy rating to Neutral, adjusting the price target to 2.25 from a previous
Read at gurufocus.com
![]() |
Vivos Therapeutics Current Investor Sentiment
Comfort Level 64
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Vivos Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Vivos Therapeutics.
News SentimentBullish | Hype SentimentBearish | Insider SentimentAcquiring |
Vivos Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Vivos Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Vivos Therapeutics Historical Investor Sentiment
Investor biases related to Vivos Therapeutics' public news can be used to forecast risks associated with an investment in Vivos. The trend in average sentiment can be used to explain how an investor holding Vivos can time the market purely based on public headlines and social activities around Vivos Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Vivos Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Vivos Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Vivos Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Vivos Therapeutics.
Vivos Therapeutics Fundamental Analysis
We analyze Vivos Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vivos Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vivos Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Vivos Therapeutics is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Vivos Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vivos Therapeutics stock to make a market-neutral strategy. Peer analysis of Vivos Therapeutics could also be used in its relative valuation, which is a method of valuing Vivos Therapeutics by comparing valuation metrics with similar companies.
Peers
Vivos Therapeutics Related Equities
HSCS | Heart Test | 8.20 | ||||
RPID | Rapid Micro | 5.44 | ||||
NAOV | NanoVibronix | 2.41 | ||||
BBLG | Bone Biologics | 0.37 | ||||
TIVC | Tivic Health | 0.31 | ||||
BJDX | Bluejay Diagnostics | 2.60 | ||||
NUWE | Nuwellis | 27.36 |
Additional Tools for Vivos Stock Analysis
When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.